Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McMurray, JJ
  • Young, JB
  • Dunlap, ME
  • Granger, CB
  • Hainer, JW
  • Michelson, EL
  • Earle, S
  • Olofsson, B
  • Ostergren, J
  • Yusuf, Salim
  • Swedberg, K
  • Pfeffer, MA

publication date

  • February 21, 2006